Sima S. Toussi

1.1k total citations · 1 hit paper
26 papers, 776 citations indexed

About

Sima S. Toussi is a scholar working on Infectious Diseases, Epidemiology and Hematology. According to data from OpenAlex, Sima S. Toussi has authored 26 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 5 papers in Epidemiology and 5 papers in Hematology. Recurrent topics in Sima S. Toussi's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Sima S. Toussi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Sima S. Toussi collaborates with scholars based in United States, United Kingdom and Japan. Sima S. Toussi's co-authors include Thomas J. Walsh, Nancy Pan, Annaliesa S. Anderson, Heather Walters, Harris Goldstein, Laura Santambrogio, Brian S. Gerstenberger, Jennifer Hammond, Noboru Mizushima and Attila Gácser and has published in prestigious journals such as Clinical Infectious Diseases, PLoS Medicine and PLoS Pathogens.

In The Last Decade

Sima S. Toussi

26 papers receiving 762 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutics for COVID-19

2023 65 citations Sima S. Toussi, Jennifer Hammond et al. Nature Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sima S. Toussi United States	14	342	213	135	121	99	26	776
Caroline Hervé Belgium	16	274 0.8×	403 1.9×	408 3.0×	297 2.5×	58 0.6×	30	1.5k
Nzeera Ketter United States	17	270 0.8×	322 1.5×	165 1.2×	219 1.8×	351 3.5×	23	1.2k
Melanie R. Nicol United States	17	477 1.4×	191 0.9×	62 0.5×	138 1.1×	125 1.3×	52	811
Takuma Shirasaka Japan	21	696 2.0×	337 1.6×	195 1.4×	210 1.7×	539 5.4×	87	1.4k
Jane A. O’Halloran United States	20	950 2.8×	308 1.4×	171 1.3×	182 1.5×	234 2.4×	68	1.4k
Javeed A. Shah United States	18	530 1.5×	383 1.8×	391 2.9×	299 2.5×	42 0.4×	40	1.5k
Natalie J. Carter New Zealand	17	152 0.4×	220 1.0×	161 1.2×	198 1.6×	32 0.3×	32	993
Alessandra Ruggiero Italy	11	321 0.9×	142 0.7×	155 1.1×	122 1.0×	308 3.1×	34	661
Celestine N. Wanjalla United States	16	268 0.8×	217 1.0×	179 1.3×	180 1.5×	221 2.2×	60	936
Lars Henning Germany	16	228 0.7×	215 1.0×	82 0.6×	143 1.2×	34 0.3×	44	912

Countries citing papers authored by Sima S. Toussi

Since Specialization

Citations

This map shows the geographic impact of Sima S. Toussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sima S. Toussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sima S. Toussi more than expected).

Fields of papers citing papers by Sima S. Toussi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sima S. Toussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sima S. Toussi. The network helps show where Sima S. Toussi may publish in the future.

Co-authorship network of co-authors of Sima S. Toussi

This figure shows the co-authorship network connecting the top 25 collaborators of Sima S. Toussi. A scholar is included among the top collaborators of Sima S. Toussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sima S. Toussi. Sima S. Toussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Ravi Shankar Prasad, Luke F. Chen, Jin Hyang Kim, et al.. (2024). Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19. Clinical Infectious Diseases. 80(3). 673–680. 3 indexed citations

Cheruvu, N., Esther van Duijn, Ioana Barbu, et al.. (2023). The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous Administration. Drug Metabolism and Disposition. 51(10). 1419–1427. 5 indexed citations

Singh, Ravi Shankar Prasad, Robert R. LaBadie, Sima S. Toussi, et al.. (2023). Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID‐19. The Journal of Clinical Pharmacology. 64(2). 145–154. 2 indexed citations

Toussi, Sima S., Jennifer Hammond, Brian S. Gerstenberger, & Annaliesa S. Anderson. (2023). Therapeutics for COVID-19. Nature Microbiology. 8(5). 771–786. 65 indexed citations breakdown →

Singh, Ravi Shankar Prasad, Gregory S. Walker, Eugene P. Kadar, et al.. (2022). Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development. Clinical Pharmacology & Therapeutics. 112(6). 1201–1206. 15 indexed citations

Toussi, Sima S., Joel M. Neutel, J. Navarro, et al.. (2022). Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment. Clinical Pharmacology & Therapeutics. 112(4). 892–900. 41 indexed citations

Singh, Ravi Shankar Prasad, Sima S. Toussi, Frances Hackman, et al.. (2022). Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir. Clinical Pharmacology & Therapeutics. 112(1). 101–111. 90 indexed citations

Baker, Thomas, Ami Patel, Sima S. Toussi, et al.. (2017). Blastomycosis during pregnancy: a case report and review of the literature. Diagnostic Microbiology and Infectious Disease. 88(2). 145–151. 6 indexed citations

Ardura, Monica I., Sima S. Toussi, Jane D. Siegel, et al.. (2016). NASPGHAN Clinical Report. Journal of Pediatric Gastroenterology and Nutrition. 63(1). 130–155. 25 indexed citations

10.

Salvatore, Christine M., Sima S. Toussi, Patricia DeLaMora, et al.. (2015). (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker forCandidaandAspergillusInfections of the Central Nervous System in Pediatric Patients. Journal of the Pediatric Infectious Diseases Society. 5(3). 277–286. 54 indexed citations

11.

Walters, Heather, Nancy Pan, Thomas J A Lehman, et al.. (2014). A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors. Clinical Rheumatology. 34(3). 457–464. 16 indexed citations

12.

Walters, Heather, Nancy Pan, Thomas J A Lehman, et al.. (2014). A17: A Prospective Study Comparing Infectious Risks, Disease Activity, and Cytokine Alterations in Children with Juvenile Idiopathic Arthritis Treated with and without Tumor Necrosis Factor‐alpha Inhibitors. Arthritis & Rheumatology. 66(S3). 1 indexed citations

13.

Toussi, Sima S., et al.. (2013). Measuring Media Use in College Students With and Without Human Immunodeficiency Virus Infection. Journal of Pediatric Health Care. 28(4). 342–349. 2 indexed citations

14.

Toussi, Sima S., Nancy Pan, Heather Walters, & Thomas J. Walsh. (2013). Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor- Inhibitors: Systematic Review of the Literature. Clinical Infectious Diseases. 57(9). 1318–1330. 75 indexed citations

15.

Pan, Nancy, Ronit Herzog, John S. Blanco, et al.. (2013). Candida albicans osteomyelitis in an infant. Journal of Pediatric Orthopaedics B. 22(5). 491–497. 5 indexed citations

16.

Toussi, Sima S., et al.. (2009). Short Communication: Methamphetamine Treatment Increases in Vitro and in Vivo HIV Replication. AIDS Research and Human Retroviruses. 25(11). 1117–1121. 51 indexed citations

17.

Tallóczy, Zsolt, Jose Martinez, Attila Gácser, et al.. (2008). Correction: Methamphetamine Inhibits Antigen Processing, Presentation, and Phagocytosis. PLoS Pathogens. 4(3). 10 indexed citations

18.

Tallóczy, Zsolt, Jose Martinez, Attila Gácser, et al.. (2008). Methamphetamine Inhibits Antigen Processing, Presentation, and Phagocytosis. PLoS Pathogens. 4(2). e28–e28. 122 indexed citations

19.

Toussi, Sima S., et al.. (2007). Prevalence of Hepatitis B and C Virus Infections in Children Infected with HIV. Clinical Infectious Diseases. 45(6). 795–798. 25 indexed citations

20.

Dadachova, Ekaterina, Mahesh Patel, Sima S. Toussi, et al.. (2006). Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral Proteins. PLoS Medicine. 3(11). e427–e427. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact